drugset / Trial / NCT07496021
Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized, Placebo-Controlled, Double-Blind, 24-Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease
Timeline
- Start
- 2026-02-23
- Primary completion
- 2027-05-31
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L. lactis CKDB001 | Unknown | — | Oral |